Pernix Therapeutics (PTX) Posts Weaker Q2 Results
Tweet Send to a FriendGet Alerts PTX Hot Sheet
Trade PTX Now!
Pernix Therapeutics Holdings, Inc. (AMEX: PTX) reports Q2 EPS of $0.01, versus $0.14 reported for the same period a year ago. Revenue for the quarter was $4.36 million, compared to $6.51 million in Q209.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
